Pharmagreen Biotech Inc. logo

Pharmagreen Biotech Inc. (PHBI)

Market Open
11 Aug, 19:55
OTC PINK OTC PINK
$
0. 00
-0
-44.4444%
$
622.21K Market Cap
- P/E Ratio
- Div Yield
9.54M Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track PHBI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PHBI trading today lower at $0, a decrease of -44.4444% from yesterday's close, completing a monthly decrease of -37.5% or $0. Over the past 12 months, PHBI stock lost -78.2609%.
PHBI is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0052%, based on the last three reports.
Pharmagreen Biotech Inc. has completed 2 stock splits, with the recent split occurring on Jul 02, 2018.
The company's stock is traded on one exchange.

PHBI Chart

Pharmagreen Biotech Inc. (PHBI) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Pharmagreen Biotech Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is PHBI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 622.21K.

Has Pharmagreen Biotech Inc. ever had a stock split?

Pharmagreen Biotech Inc. had 2 splits and the recent split was on Jul 02, 2018.

Pharmagreen Biotech Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Peter Wojcik CEO
OTC PINK Exchange
71716C109 CUSIP
CA Country
- Employees
- Last Dividend
10 Mar 2009 Last Split
- IPO Date

Overview

Pharmagreen Biotech Inc. is a North American nutraceutical company specializing in the development of products derived from a combination of therapeutic plants and fungi. With a focus on leveraging the medicinal properties of natural substances, Pharmagreen aims to support the well-being of the human mind and body through its innovative formulations. The company not only focuses on product development but also offers consulting services to assist other entities in plant genetic selection, tissue culture technologies for the production of starter plantlets, and the establishment of standard operating procedures (SOPs) for plant cultivation and preservation. Based in Coquitlam, Canada, Pharmagreen has strategically positioned itself in the health and wellness market by distributing its products online, utilizing popular platforms such as Amazon and Shopify.

Products and Services

  • MaxGenomic Supplement

    A proprietary blend of medicinal mushrooms and plants formulated by Pharmagreen Biotech Inc. This product is designed to support both mental and physical health by harnessing the therapeutic benefits of its natural ingredients. MaxGenomic Supplement represents the company's commitment to providing consumers with natural health solutions that are both innovative and scientifically backed.

  • Consulting Services

    Pharmagreen offers a wide range of consulting services targeting the agricultural biotech sector. These services include assistance with plant genetic selection to identify the most beneficial traits for health and medicinal purposes. Additionally, the company specializes in tissue culture technologies, providing solutions for the mass production of starter plantlets, ensuring consistency and high quality. Pharmagreen also advises on the development of SOPs for the cultivation and live storage of plant species, ensuring that clients can achieve sustainable and profitable cultivation practices.

Contact Information

Address: 2987 Blackbear Court
Phone: 702-803-9404